iCAC Device vs OMRON VitalSight

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

iCAC Device

by Bunkerhill Health

OMRON VitalSight

by OMRON Healthcare

AI Verdict

Tool A is an AI-powered diagnostic aid for radiologists, focusing on the opportunistic detection and quantification of coronary artery calcium from existing CT scans to assess cardiovascular disease risk. Tool B is a remote patient monitoring service for physicians, designed to manage hypertension through continuous blood pressure data collection from at-home devices. They address different clinical needs within cardiovascular care, with one focused on diagnostic risk assessment and the other on ongoing disease management.

Choose iCAC Device if…

Choose iCAC Device if your radiology department aims to enhance early cardiovascular disease detection by opportunistically analyzing existing non-contrast, non-gated chest CT scans. This AI-powered tool is ideal for quantifying coronary artery calcium burden to identify at-risk patients without requiring additional imaging or patient appointments.

View iCAC Device →

Choose OMRON VitalSight if…

Choose OMRON VitalSight if your practice requires a robust remote patient monitoring service to effectively manage hypertension and improve patient adherence. This solution is best suited for physicians seeking to integrate automated blood pressure data directly into EHRs, receive alerts for out-of-range readings, and provide patients with convenient, pre-set home monitoring kits.

View OMRON VitalSight →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	iCAC Device	OMRON VitalSight
Pricing	Contact for pricing	Reimbursement-based
Deployment	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).	Cloud-based (physician dashboard) with at-home patient devices.
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

OMRON VitalSight

OMRON VitalSight offers a more comprehensive usability experience by simplifying remote patient monitoring for both clinicians and patients. Its pre-set devices and direct-to-patient delivery minimize setup hurdles, making it highly accessible for a broader user base, including those without technical expertise.

Clinical Value

Tie

Both tools offer significant clinical value by addressing critical cardiovascular health issues with FDA-cleared solutions. iCAC Device provides early detection of cardiovascular disease by repurposing existing imaging data, while OMRON VitalSight enables proactive management of hypertension through continuous remote monitoring and timely alerts.

Pricing & Value

OMRON VitalSight

OMRON VitalSight clearly outlines a reimbursement-based pricing model that minimizes costs for both patients and physicians, including no setup or device fees. This transparency and favorable cost structure provide a much clearer and more accessible value proposition compared to iCAC Device's 'contact for pricing' approach.

Enterprise Readiness

OMRON VitalSight

OMRON VitalSight explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare. While iCAC Device integrates with existing systems and is FDA-cleared, its JSON indicates these critical compliance details require direct vendor contact, suggesting less immediate transparency.

Innovation

iCAC Device

iCAC Device demonstrates higher innovation by applying advanced deep-learning AI to extract novel, clinically significant information (CAC quantification) from opportunistically identified routine CT scans. This approach maximizes the utility of existing diagnostic data for early disease detection, representing a significant advancement in leveraging AI for preventative care.

Support & Docs

OMRON VitalSight

OMRON VitalSight clearly provides comprehensive support and documentation, including accessible instruction manuals, dedicated customer service, and patient technical support. In contrast, the available information for iCAC Device does not explicitly detail public support channels or documentation, making OMRON VitalSight the clear winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	iCAC Device	OMRON VitalSight
Primary Function	FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.	Remote patient monitoring service for US physicians, offering connected blood pressure monitors and data hubs that securely integrate with EHRs to manage hypertension and improve patient outcomes.
Company	Bunkerhill Health	OMRON Healthcare
Categories	Cardiology AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Radiology	Cardiology, Internal Medicine, Nephrology
Key Feature Example	Analyzes routine, non-contrast, non-gated chest CT scans for estimated CAC.	Connected blood pressure monitor and data hub kit for secure, digital data sharing.

Videos

Demos, reviews, and walkthroughs featuring iCAC Device and OMRON VitalSight.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiovascular care, and what specific patient populations are best suited for each?

The iCAC Device integrates into radiology workflows by analyzing routine chest CT scans to opportunistically identify and quantify coronary artery calcium, aiding in early cardiovascular disease detection. It is best suited for patients undergoing chest CTs for other reasons, where incidental CAC detection can inform cardiovascular risk. OMRON VitalSight integrates into primary care or cardiology workflows for hypertension management, providing remote blood pressure data and alerts directly to the physician's EMR or dashboard. This service is ideal for patients with diagnosed hypertension requiring ongoing monitoring and proactive management.

What is the depth and nature of EHR integration for each tool, specifically regarding data flow and physician interaction within the EHR?

The iCAC Device integrates with EHRs via the Carebricks platform, pushing visual representations and quantitative estimates of CAC burden into the patient's record for review by radiologists and cardiologists. This allows for streamlined access to adjunctive diagnostic information within the existing EHR environment. OMRON VitalSight offers direct EHR/EMR integration, securely sending blood pressure data and automatic notifications for out-of-range readings to the physician's EMR in real-time. This enables physicians to manage hypertension and make informed treatment decisions directly within the patient's comprehensive health record.

What is the reported accuracy or sensitivity of the iCAC Device in detecting and quantifying coronary artery calcium?

The iCAC Device utilizes deep-learning algorithms to provide both visual representations and exact quantitative estimates of CAC burden in Agatston units. In a pivotal testing study, the iCAC device demonstrated an overall alignment rate of 79.7% with ground truth calcium score groups and positive predictive values ranging from 68.1% to 90.1% for different calcium score groupings.

What is the typical learning curve for physicians and their staff to effectively utilize each tool, and how quickly can a practice expect to see clinical value?

For the iCAC Device, the learning curve for radiologists is likely minimal as it provides adjunctive information within existing CT scan review workflows, enabling quick realization of clinical value through opportunistic CAC identification. OMRON VitalSight is designed for ease of use with pre-set patient devices and a straightforward physician dashboard, suggesting a low learning curve for staff and rapid value through improved hypertension management and patient engagement.

Do these tools offer robust audit-trail features to track data access, modifications, and clinical decisions made based on the provided information?

The iCAC Device, as an AI algorithm providing diagnostic adjunctive information, is expected to maintain audit logs to track when and by whom the CAC analysis was accessed and reviewed, ensuring accountability in the diagnostic process. OMRON VitalSight, as a remote patient monitoring service, would likely include audit trails for patient data access, changes to personalized thresholds, and notifications sent, supporting compliance and clinical oversight.

What considerations should a multi-site healthcare system or large practice take into account for implementing and scaling each solution, and are customer references available?

For the iCAC Device, multi-site rollouts would focus on seamless integration with existing PACS or DICOM routers across different locations. Bunkerhill Health has implemented its algorithm in various health systems, including UTMB, demonstrating real-world implementation and scalability. For OMRON VitalSight, scaling across multiple sites involves managing patient kit distribution and ensuring consistent EHR integration across different clinics, with customer references available from collaborations with health systems like Mount Sinai and Northwestern Medicine.